WANG Feng. Influence of linagliptin on the blood glucose change in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2014, (13): 99-101. DOI: 10.7619/jcmp.201413033
Citation: WANG Feng. Influence of linagliptin on the blood glucose change in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2014, (13): 99-101. DOI: 10.7619/jcmp.201413033

Influence of linagliptin on the blood glucose change in patients with type 2 diabetes mellitus

More Information
  • Published Date: September 10, 2014
  • Objective To investigate the influence of linagliptin on the blood glucose change in patients with type 2 diabetes mellitus (T2DM)and to evaluate its safety.Methods A total of 98 patients diagnosed with T2DM admitted in our hospital were randomly divided into treatment group and control group,49 cases for each.Control group was treated with insulin glargine concomitant with dimethyldiguanide,on which basis treatment group was added with 5 mg /d linagliptin.Fast-ing plasma glucose (FPG),plasma glucose 2 h after meals (2hPG),glycosylated hemoglobin (HbAlc),body mass index (BMI)and adverse response rate before and 12 weeks after treatment were compared between two groups.Results After 12 weeks treatment,FPG,2hPG and HbAlc reduced evidently than treatment before,and were more lower in treatment group than in control group (P <0.05),while BMI had no significant difference before and after treatment in both groups (P > 0.05 ).The main adverse responses included nasopharyngitis,hypoglycemia, headache,gastrointestinal reactions and upper respiratory infection,in which only upper respiratory infection rate was significantly different between two groups (P <0.05).Conclusion linagliptin plus insulin glargine concomitant with dimethyldiguanide can effectively control blood glucose changes in patients with T2DM,which deserves to be widely used in clinic.
  • 中国老年学学会老年医学会老年内分泌代谢专业委员会, 老年糖尿病诊疗措施专家共识编写组. 老年糖尿病诊疗措施专家共识(2013 年版) [J]. 中华内科杂志, 2014(3):243.
    Rosenstock J, Dal ey G, Maasi-benedetti G, et a1. Re-duced hypoglycemia risk with insulin glargine:a meta-anal-ysis comparing insulin glargine with human NPH insulin in type 2 diabetes [J]. DIABETES CARE, 2005(4):950.
    Amori R, Lau J, Pittas A. Efficacy and safety of incertin therapy in type 2 diabetes [J]. JAMA:the Journal of the American Medical Association, 2007(2):194.
    Holman R R, Thome K I, Farmer A J. Addition of biphasic, prandialor basal insulin to oral therapy in type 2 dia-betes [J]. N Ensl J Med, 2007, (17):1716.
    Park C Y, Kang J G, Chon S. Comparison between the Therapeutic Effect of Metformin, Glimepiride and Their Combination as an Add-On Treatment to Insulin Glargine in Uncontrol ed Patients with Type 2 Diabetes [J]. PLoS One, 2014(3):e87799.
    Nauck M A. Incretin-based therapies for type 2 diabetes mel itus:properties, functions, and clinical implications [J]. American Journal of Medicine, 2011, (1 Suppl):S3.
    Forst T, Uhlig-Laske B, Ring A. The oral DP-4inhibitor linagliptin significantly lowers HbA1c after 4 weeks oftreatment in patients with type 2 diabetes mel itus [J]. Di-abetesObes Metab, 2011(6):542.
    Graefe-Mody U, Rose P, Retlich S. Pharmacokinet-ics of linagliptin in subjects with hepatic impairment [J]. British Journal of Clinical Pharmacology(England), 2012, (10):1365.
    Schernthaner G, Barnett A H, Emser A. Safety and tolerability of linagliptin:a pooled analysis of data from ran-domized control ed trials in 3572 patients with type 2diabetes mel itus [J]. Diabetes Obesity & Metabolism, 2012(5):470.
    del P S, Baenett A, Huisman H. Effect of linagliptin monotherapy on glycaemic control and markers of β-cellfunction in patients with inadequately control ed type 2diabetes:a randomized control ed trial [J]. Diabetes Obesity & Metabolism, 2011(3):258.
    Taskinen M R, Rosenstock J, Tamminen I. Safety and efficacy of linagliptin as add-on therapy to metformin inpa-tients with type 2 diabetes:a randomized, double-blind, placebo-control ed study [J]. Diabetes Obesity & Metabolism, 2011(1):65.
    Gomis R, Espadero R M, Jones R. Efficacy and safety of initial combination therapy with linagliptin and pioglitazone in patients with inadequately control ed type 2diabetes:a ran-domized, double-blind, placebo-control ed study [J]. Dia-betes Obes Metab, 2011(7):653.
  • Cited by

    Periodical cited type(27)

    1. 韩维静,赵伟涛,张帅通. 冰冻切片病理诊断在甲状腺微小乳头状癌术中应用体会. 延边大学医学学报. 2025(01): 52-54 .
    2. 余萱玺,龙秀荣,张学平. 术中冰冻切片检查用于甲状腺微小乳头状癌诊断中的准确性分析. 生命科学仪器. 2024(01): 165-167 .
    3. 刘建,张立英,贾兴东,冯艳玉. 甲状腺癌冰冻切片病理不能明确诊断的临床因素分析. 中国现代医生. 2024(18): 38-42 .
    4. 李军,许研,卓倩. 甲状腺微小乳头状癌的术中冰冻病理诊断探讨. 系统医学. 2024(10): 46-48 .
    5. 毛左乾. 术中冰冻切片病理检查诊断甲状腺微小癌的价值分析. 中国社区医师. 2024(16): 86-88 .
    6. 齐彬,栗玉娇,周平安,张翔. 甲状腺微小乳头状癌术中冰冻切片病理诊断准确性分析. 系统医学. 2024(18): 167-169+198 .
    7. 莫林,韩泽贤,欧范妍,梁业志,韦康来. 术中快速冰冻病理切片检查在诊断甲状腺结节中的应用效果. 医药前沿. 2024(20): 47-49 .
    8. 赖丽雅,廖志东,卢裕,郑渝兰,钟伟樑. 甲状腺乳头状增生与甲状腺乳头状癌术中冰冻切片与石蜡切片病理诊断结果的对比分析. 齐齐哈尔医学院学报. 2024(22): 2162-2166 .
    9. 张檑,张玲,王义龙. 病理切片机在甲状腺癌手术患者病理检查中的应用及可信性分析研究. 现代仪器与医疗. 2023(01): 29-32 .
    10. 崔小光,陈昌伟. 冰冻切片对甲状腺微小乳头状癌术中病理诊断的准确性及价值. 中国卫生标准管理. 2023(04): 110-113 .
    11. 王惠国. 甲状腺微小乳头状癌诊断中术中冰冻病理的应用价值体会. 中国实用医药. 2023(09): 96-98 .
    12. 段鸿梅,蔡为民,盛仁明,周燕芳. 术中冰冻病理检查对甲状腺微小乳头状癌诊断的准确率分析. 系统医学. 2023(02): 46-49 .
    13. 罗燕. 冰冻病理技术在甲状腺乳头状癌诊断中的效果分析. 现代诊断与治疗. 2023(11): 1688-1690 .
    14. 杨晓波,李俊,张爱兵. 术中冰冻切片技术诊断甲状腺乳头状癌的价值. 系统医学. 2023(14): 171-173 .
    15. 许研. 甲状腺冰冻与石蜡切片的病理诊断价值观察. 中国医药指南. 2022(04): 74-76+80 .
    16. 刘军. 卵巢肿瘤术中冰冻切片的病理诊断分析及临床价值. 中国卫生标准管理. 2022(03): 183-186 .
    17. 孟峰芳. 甲状腺冰冻切片病理检查在鉴别其良恶性价值中的应用. 中国卫生标准管理. 2022(07): 73-75 .
    18. 王超柱,付冬妍. 冰冻切片对甲状腺微小癌术中病理诊断的准确性及漏诊率、误诊率分析. 中国医药科学. 2022(15): 182-185 .
    19. 李晓,曹卓,李明显,刘红英,黄镇栋,郑广娟,何青莲. 一种生物色标在冰余石蜡制片中的应用体会. 临床与实验病理学杂志. 2022(09): 1141-1142 .
    20. 李明显,周娜,郑细闰,杜晓华,李晓,郑广娟,何青莲,汤丽鹏. 一种红色标签纸在甲状腺小病灶冰冻切片过程中的应用体会. 中国临床解剖学杂志. 2022(06): 748-750 .
    21. 李轩飞,张静文. 术中冰冻切片与术后石蜡切片对PTMC病理诊断的效果分析. 菏泽医学专科学校学报. 2022(04): 26-29+33 .
    22. 徐鹏育. 术中冰冻切片病理诊断甲状腺微小乳头状癌的价值. 临床医学研究与实践. 2022(30): 107-109 .
    23. 陈海敏,江沂,刘婉,江桂英. 甲状腺良恶性鉴别中应用冰冻切片及石蜡切片病理检查的价值. 人人健康. 2021(08): 66-67 .
    24. 成瑶. 术中快速冰冻切片在甲状腺乳头状癌诊断中的应用分析. 临床医学工程. 2021(05): 651-652 .
    25. 杨丽英,闵文,朱杰,谭永兴. 甲状腺微小乳头状癌术中冰冻切片病理诊断的准确性及相关影响因素. 临床医学研究与实践. 2021(31): 36-38 .
    26. 张宏岩. 术中冰冻切片病理诊断在甲状腺微小乳头状癌中的应用价值. 中国实用医药. 2021(31): 202-204 .
    27. 刘爽,宋秀平,周宝华. 甲状腺冰冻切片与石蜡切片的病理诊断价值比较. 当代医学. 2021(34): 143-144 .

    Other cited types(0)

Catalog

    Article views (180) PDF downloads (0) Cited by(27)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return